MUC1 and cancer: Galectin-3 levels were also increased in the blood stream of cancer patients and this promoted cancer metastasis via binding to cell surface-associated mucin 1 (MUC1) on cancer cells, in turn leading to the exposure of smaller cell-surface adhesion molecules/ligands including CD44 and ligand(s) for E-selectin [12].